Singapore, July 16 -- Telix Pharmaceuticals has officially opened a multi-million dollar radiopharmaceutical research, manufacturing and treatment facility in Melbourne, expanding and strengthening Australia's capability in one of the world's fastest-growing areas of cancer diagnosis and treatment.

Telix Manufacturing Solutions North Melbourne (TMSNM) is a purpose-built site that combines radiochemistry laboratories, clinical product manufacturing, patient dose administration and imaging. It is a first-of-its-kind Australian facility that integrates these capabilities at a single location.

The facility will help address manufacturing capacity constraints and the need to make and administer radiopharmaceutical doses in close proximity to...